Patents by Inventor Mark RANSBOTTOM

Mark RANSBOTTOM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
    Publication number: 20260216158
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing axitinib dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: March 10, 2026
    Publication date: July 30, 2026
    Inventors: Charles D. BLIZZARD, Erica KAHN, Peter JARRETT, Rabia GURSES-OZDEN, Rami EL-HAYEK, Elizabeth BRAUN, Joseph IACONA, Chintan PATEL, Mark RANSBOTTOM, Olivia SHERMAN, William ISOM
  • OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
    Publication number: 20260207571
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing axitinib dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: September 16, 2025
    Publication date: July 23, 2026
    Inventors: Charles D. BLIZZARD, Erica KAHN, Peter JARRETT, Rabia GURSES-OZDEN, Rami EL-HAYEK, Elizabeth BRAUN, Joseph IACONA, Chintan PATEL, Mark RANSBOTTOM, Olivia SHERMAN, William ISOM
  • Ocular implant containing a tyrosine kinase inhibitor
    Patent number: 12453724
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing axitinib dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Grant
    Filed: April 9, 2025
    Date of Patent: October 28, 2025
    Assignee: OCULAR THERAPEUTIX, INC.
    Inventors: Charles D. Blizzard, Erica Kahn, Peter Jarrett, Rabia Gurses-Ozden, Rami El-Hayek, Elizabeth Braun, Joseph Iacona, Chintan Patel, Mark Ransbottom, Olivia Sherman, William Isom
  • OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITORI
    Publication number: 20250235438
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing axitinib dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: April 9, 2025
    Publication date: July 24, 2025
    Inventors: Charles D. BLIZZARD, Erica KAHN, Peter JARRETT, Rabia GURSES-OZDEN, Rami EL-HAYEK, Elizabeth BRAUN, Joseph IACONA, Chintan PATEL, Mark RANSBOTTOM, Olivia SHERMAN, William ISOM